Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Sir Mike Richards appointed England’s chief inspector of hospitals

HSJ reports that former cancer tsar will become NHS’ 'whistleblower-in-chief'

- PMLiVE

Merck KGaA to research cancer drug with Chinese biotech

German pharma firm teams up with BeiGene on BRAF inhibitor

- PMLiVE

Restless youth: tomorrow’s leaders in healthcare

With the speed and force at which technology is shaping the world of medicine and healthcare, isn’t it time we begin allocating resources to those who can execute these changes,...

Biogen Idec building

Biogen Idec says Tecfidera launch delayed in Europe

Company wants to resolve patent and regulatory data protection issues for oral MS drug

- PMLiVE

Novo files for EU approval of Tresiba/ Victoza combination in diabetes

Ideglira combines insulin degludec and GLP-1 analogue

- PMLiVE

GSK eyes first-line use for leukaemia drug Arzerra

Positive phase III trial results back regulatory filings for earlier use

- PMLiVE

PhRMA deputy VP returns to World Health Advocacy

Christoper Ward is appointed senior partner at health policy specialist agency he founded

- PMLiVE

Eylea set to challenge Lucentis in UK after NICE recommendation

Bayer’s medicine recommended for NHS use to treat wet AMD

- PMLiVE

Translating value in pharma marketing

A new approach to marketing could build upon Kotler's idea of 'exchanging value' to bring genuine beneficial outcomes for customers, patients and society at large

- PMLiVE

FDA clears two GSK melanoma drugs

Tafinlar and Mekinist approved in the US along with companion diagnostic

EU flag

EU Parliament panel backs updated clinical trials regulations

But pharma industry concerned about measures to increase transparency

National Institute for Health and Care Excellence NICE logo

NICE reverses negative guidance for Forxiga in diabetes

Final draft guidance backs the use of BMS/AstraZeneca’s SGLT-2 inhibitor in certain patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links